Loading...
Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action
Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. The prognosis remains dismal with little advance in treatment. Metformin is a drug widely used for the treatment of type II diabetes. Recent epidemiologic data revealed that oral administration of metformin...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3648476/ https://ncbi.nlm.nih.gov/pubmed/23667692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0063969 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|